Physician

Jay Chong Wang, MD

According to 2025 Medicare claims, Jay Wang, MD (NPI: 1225443997) practices ophthalmology in the San Jose-Sunnyvale-Santa Clara, CA market, with the plurality of this provider's patient population coming from Santa Clara, CA. This provider's primary affiliated billing organization is NORTHERN CALIFORNIA RETINA VITREOUS ASSOCIATES MEDICAL GROUP, INC. (NPI: 1538275920; TIN: 942906234) and primary practice location at 93940-2918.

Wang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 877 traditional Medicare patients, billed 41,725 HCPCS/CPT codes, and received $2,545,422 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 434 prescription claims across 112 beneficiaries totaling $15,769 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 12 records totaling $2,156. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $10,649 to $2,545,422. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $14,714 and ending at $15,769. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	63	101	$10,649
2019	146	246	$22,334
2020	162	470	$64,717
2021	407	1,936	$407,154
2022	731	9,585	$2,001,727
2023	827	25,131	$2,329,515
2024	877	41,725	$2,545,422

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	58	127	$14,714
2016	46	66	$4,353
2017	80	173	$14,593
2018	179	502	$48,734
2019	160	467	$34,520
2020	88	245	$15,442
2021	55	199	$21,107
2022	90	339	$17,907
2023	94	430	$23,291
2024	112	434	$15,769

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
67028	Injection of drug into eye	282	1,344	$109
92014	Established patient complete exam of visual system	525	540	$109
92012	Established patient problem focused exam of visual system	441	660	$91
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	213	280	$65
92134	Imaging of retina	823	2,499	$38

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	132	4,282	$4,100
Bromfenac Sodium	Bromfenac Sodium	22	709	$3,917
Ketorolac Tromethamine	Ketorolac Tromethamine	107	3,648	$1,900
Difluprednate	Difluprednate	13	450	$1,453
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	78	1,888	$779

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	12	$2,156	Carl Zeiss Meditec, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jay Chong Wang, MD?

Tedicare shows public-source Medicare data for Jay Chong Wang, MD (NPI 1225443997), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jay Chong Wang, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jay Chong Wang, MD?

Jay Chong Wang, MD is linked to NORTHERN CALIFORNIA RETINA VITREOUS ASSOCIATES MEDICAL GROUP, INC. (billing NPI 1538275920) in the available physician profile data.

Does Jay Chong Wang, MD have Open Payments data?

Jay Chong Wang, MD has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.